Search by Drug Name or NDC

    NDC 68180-0202-05 SUPRAX 100 mg/5mL Details

    SUPRAX 100 mg/5mL

    SUPRAX is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is CEFIXIME.

    Product Information

    NDC 68180-0202
    Product ID 68180-202_a71c02a7-148f-42cb-b323-34c7bcfb0bec
    Associated GPIs 02300060001910
    GCN Sequence Number 009182
    GCN Sequence Number Description cefixime SUSP RECON 100 MG/5ML ORAL
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 33120
    HICL Sequence Number 003999
    HICL Sequence Number Description CEFIXIME
    Brand/Generic Brand
    Proprietary Name SUPRAX
    Proprietary Name Suffix n/a
    Non-Proprietary Name CEFIXIME
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/5mL
    Substance Name CEFIXIME
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065129
    Listing Certified Through 2022-12-31

    Package

    NDC 68180-0202-05 (68180020205)

    NDC Package Code 68180-202-05
    Billing NDC 68180020205
    Package 6 BOTTLE in 1 CARTON (68180-202-05) / 10 mL in 1 BOTTLE (68180-202-04)
    Marketing Start Date 2004-03-01
    NDC Exclude Flag N
    Pricing Information N/A